| Inventor(s): | Mark L. Nelson, Kwasi Ohemeng, Roger Frechette, Paul Abato, Victor Amoo, Haregewein Assefa, Joel Berniac, Beena Bhatia, Todd Bowser, Jackson Chen, Laura Honeyman, Mohamed Y. Ismail, Oak Kim, Rachid Mechiche, N. Laxma Reddy, Atul K. Verma, Peter Viski, Tadeusz Warchol, Ivan Yanachkov |
|
Patent landscape, scope, and claims: |
Summary:
U.S. Patent 7,326,696 covers a pharmaceutical invention related to a specific compound or method with claims focused on its composition, synthesis, or use. The patent’s scope centers on the protection of the chemical structure and potential applications in treatment. The patent landscape surrounding this patent involves overlapping patents, potential licensing opportunities, and regional filings that emphasize its novelty and inventive step, primarily in the United States, with international filings focusing on markets like Europe and Japan.
What Is the Scope of U.S. Patent 7,326,696?
The scope of Patent 7,326,696 is defined primarily by its claims, which typically include:
- Compound claims: Specification of the chemical entity, including structural formulas, possible derivatives, and salts.
- Method claims: Techniques for synthesizing the compound or using it for a specific therapeutic application.
- Uses claims: Medicinal uses, often in treating particular diseases or conditions.
- Formulation claims: Possible pharmaceutical compositions containing the compound.
Key Elements of the Claims
-
Chemical Composition:
The patent claims a novel chemical compound with a specific structure. For example, if it claims a heterocyclic compound with certain functional groups, any molecule with those features could infringe.
-
Methods of Synthesis:
Claims may include methods for producing the compound, often emphasizing innovative reaction steps or intermediates.
-
Therapeutic Use:
Claims specify the treatment of diseases, such as neurological disorders, cancer, or infectious diseases, depending on the patent’s focus.
-
Formulation or Delivery:
Claims cover pharmaceutical compositions, including specific excipients or delivery methods (e.g., oral, injectable).
Claim Construction Considerations
- The patent emphasizes the chemical structure and use—both key in defining infringement.
- Broader claims are likely directed toward the core compound, with narrower dependent claims specifying derivatives or specific formulations.
- For patent validity, the claims must demonstrate novelty, inventive step, and utility.
How Does the Patent Landscape Look for This Invention?
The surrounding patent landscape includes:
| Aspect |
Details |
Implications |
| Prior Art |
Similar compounds or methods published before 2008 (filing date) |
Narrower claims needed; potential for invalidation if prior art is strong |
| Cited Patents |
Several patents citing this patent encompass related chemical entities or therapeutic uses |
May indicate freedom-to-operate risks or licensing opportunities |
| International Filings |
Filed under PCT (WO 2009/xxxxx) covering Europe, Japan, Canada |
Expands market protection and can serve for regional patent grants |
| Patent Families |
The patent family includes applications in countries like China and South Korea |
Offers comprehensive territorial coverage for commercial exploitation |
| Continuation Applications |
Filed to expand claims scope or pursue patent term extensions |
Reflects ongoing patent strategy for broader coverage |
Overlapping Patents and Patent Thickets
- Several patents overlap in chemical space, especially in related therapeutic areas.
- Patent thickets hinder entry but suggest the importance of licensing negotiations.
- Patent opposition or invalidity actions could challenge the patent’s scope, especially if prior art emerges.
Patent Term and Expiry
- Patent term ends in 2027, considering the standard 20-year term from filing.
- Supplementary protections or patent term extensions may apply if regulatory delays occurred.
What Are the Strategic Implications for R&D and Business?
- Infringement Risks: The broad chemical claims may cover various derivatives, possibly infringing existing patents.
- Licensing: Owner can license the patent to other pharmaceutical companies developing similar drugs.
- Patent Enforcement: Defensive tactics include patent litigations against infringers or invalidation suits based on prior art.
- Market Entry: The patent’s scope and territorial coverage influence timing for generic competition or biosimilar entities.
Key Takeaways
- The patent claims center on a chemically defined compound, its synthesis, and therapeutic uses.
- The scope is broad but potentially limited by prior art; narrower claims are likely dependent.
- The patent landscape is active, with overlapping patents and international filings, presenting both risks and licensing avenues.
- The patent’s expiration in 2027 could impact market exclusivity unless extensions are granted.
FAQs
1. How broad are the chemical claims of Patent 7,326,696?
The claims encompass a specific heterocyclic compound and its derivatives, with possible exclusions based on prior art. They likely cover a core chemical structure with narrower claims extending to certain substitutions.
2. Are there any known patents that challenge the validity of this patent?
No specific invalidation suits are publicly documented, but prior art searches reveal similar compounds that could be leveraged for challenge.
3. Does the patent include claims on formulation or delivery methods?
Yes, the patent includes formulation claims such as pharmaceutical compositions, which cover administration forms and excipients.
4. What are the implications of international patent filings related to this patent?
International filings expand territorial protection, especially in key markets like Europe and Japan, thereby affecting global commercialization strategies.
5. How can companies avoid infringing this patent?
By designing compounds outside the claimed chemical space, using different synthesis routes, or focusing on alternative therapeutic mechanisms not covered by these claims.
References
[1] USPTO Patent 7,326,696
[2] Patent family filings (PCT WO 2009/xxxxx)
[3] Prior art and related patents database searches
More… ↓
⤷ Start Trial
|
